MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
702.73%
Quick Ratio
702.73%
Cash Ratio
624.07%
Debt to Asset Ratio
15.10%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Grant receivables
    • Restricted cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred grant income, current
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
34,012
31,130
36,810
39,334
Grant receivables
2,951
3,657
9,923
1,900
Prepaid expenses and other current assets
586
932
1,068
1,160
Restricted cash equivalents
750
95
190
489
Total current assets
38,299
35,814
47,991
42,883
Property and equipment, net
87
77
93
159
Right-of-use assets, operating leases
510
249
306
353
Total assets
38,896
36,140
48,390
43,395
Accounts payable
673
3,850
1,119
827
Accrued expenses
3,833
1,694
11,995
3,923
Deferred grant income, current
777
220
367
1,736
Operating lease liabilities, current
89
95
136
168
Other current liabilities
78
194
307
-
Total current liabilities
5,450
6,053
13,924
6,654
Operating lease liabilities, non-current
422
176
195
212
Total liabilities
5,872
6,229
14,119
6,866
Common stock, 0.001 par value, 250,000,000 shares authorized 95,055,773 and 88,904,161 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
95
90
90
88
Additional paid-in capital
240,078
233,038
232,828
231,745
Accumulated deficit
-207,149
-203,217
-198,647
-195,304
Total stockholders' equity
33,024
29,911
34,271
36,529
Total liabilities and stockholders' equity
38,896
36,140
48,390
43,395
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$34,012K (216.60%↑ Y/Y)Grant receivables$2,951K (-53.05%↓ Y/Y)Restricted cashequivalents$750K (-7.86%↓ Y/Y)Prepaid expenses andother current assets$586K (-51.45%↓ Y/Y)Total current assets$38,299K (101.06%↑ Y/Y)Right-of-use assets,operating leases$510K (27.82%↑ Y/Y)Property and equipment,net$87K (-50.00%↓ Y/Y)Total assets$38,896K (98.23%↑ Y/Y)Total liabilities andstockholders' equity$38,896K (98.23%↑ Y/Y)Total stockholders'equity$33,024K (369.83%↑ Y/Y)Total liabilities$5,872K (-53.37%↓ Y/Y)Accumulated deficit-$207,149K (-8.81%↓ Y/Y)Additional paid-in capital$240,078K (21.66%↑ Y/Y)Total currentliabilities$5,450K (-55.92%↓ Y/Y)Operating leaseliabilities, non-current$422K (84.28%↑ Y/Y)Common stock, 0.001 parvalue, 250,000,000...$95K (46.15%↑ Y/Y)Accrued expenses$3,833K (-59.10%↓ Y/Y)Deferred grant income,current$777K (-60.80%↓ Y/Y)Accounts payable$673K (-12.71%↓ Y/Y)Operating leaseliabilities, current$89K (-55.05%↓ Y/Y)Other currentliabilities$78K (90.24%↑ Y/Y)

COGNITION THERAPEUTICS INC (CGTX)

COGNITION THERAPEUTICS INC (CGTX)